Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Needle-Free Peptide Delivery Market Research Report 2025
Global Needle-Free Peptide Delivery Market Research Report 2025
Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 91 Pages
Report ld: 4805876
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Needle-Free Peptide Delivery Market Size(US$)
CAGR 2025-2031
8.4%
Market Size,2031
USD 557
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 343 million
Market Forecast in 2031(Value)
US$ 557 million
CAGR
8.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Needle-Free Peptide Delivery was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 557 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Needle-Free Peptide Delivery is a technology system that efficiently delivers peptide drugs to target sites in the body in a non-invasive or minimally invasive manner without the use of traditional injection needles. Its core goal is to solve the problems of pain, fear, infection risk and low patient compliance caused by traditional injection, while ensuring that peptide drugs (usually with large molecular weight, strong hydrophilicity, and easy to be degraded by enzymes) can break through physiological barriers such as skin and mucous membranes to achieve effective absorption and exert pharmacological effects.
North American market for Needle-Free Peptide Delivery is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Needle-Free Peptide Delivery is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Needle-Free Peptide Delivery in Hospitals & Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Needle-Free Peptide Delivery include Zynerba Pharmaceuticals, Portal Instruments, Crossject Société Anonyme, 3M, Antares Pharma, Zogenix, PharmaJet, Inovio Pharmaceuticals, Bioject Medical Technologies, Valeritas, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Needle-Free Peptide Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Peptide Delivery.
The Needle-Free Peptide Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Needle-Free Peptide Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Peptide Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Zynerba Pharmaceuticals
- Portal Instruments
- Crossject Société Anonyme
- 3M
- Antares Pharma
- Zogenix
- PharmaJet
- Inovio Pharmaceuticals
- Bioject Medical Technologies
- Valeritas
- Takeda Pharmaceutical Company
- Medical International Technology
- Endo International
- Akra Dermojet
- TheraJect
- TARI Labs
- InsuJet
- Gerresheimer AG
- Mitsubishi Tanabe Pharma Corporation
- Novartis AG
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Jet Injectors
- Inhaler Technology
- Transdermal Patch Technology
- Electroporation
- Laser-Powered Systems
- Microporation
Segment by Application
- Hospitals & Clinics
- Home Care
- Research Laboratories
- Pharmaceutical & Biotech Companies
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Needle-Free Peptide Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Needle-Free Peptide Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Jet Injectors
1.2.3 Inhaler Technology
1.2.4 Transdermal Patch Technology
1.2.5 Electroporation
1.2.6 Laser-Powered Systems
1.2.7 Microporation
1.3 Market by Application
1.3.1 Global Needle-Free Peptide Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Home Care
1.3.4 Research Laboratories
1.3.5 Pharmaceutical & Biotech Companies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Needle-Free Peptide Delivery Market Perspective (2020-2031)
2.2 Global Needle-Free Peptide Delivery Growth Trends by Region
2.2.1 Global Needle-Free Peptide Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Needle-Free Peptide Delivery Historic Market Size by Region (2020-2025)
2.2.3 Needle-Free Peptide Delivery Forecasted Market Size by Region (2026-2031)
2.3 Needle-Free Peptide Delivery Market Dynamics
2.3.1 Needle-Free Peptide Delivery Industry Trends
2.3.2 Needle-Free Peptide Delivery Market Drivers
2.3.3 Needle-Free Peptide Delivery Market Challenges
2.3.4 Needle-Free Peptide Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Needle-Free Peptide Delivery Players by Revenue
3.1.1 Global Top Needle-Free Peptide Delivery Players by Revenue (2020-2025)
3.1.2 Global Needle-Free Peptide Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Top Needle-Free Peptide Delivery Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Needle-Free Peptide Delivery Revenue
3.4 Global Needle-Free Peptide Delivery Market Concentration Ratio
3.4.1 Global Needle-Free Peptide Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Needle-Free Peptide Delivery Revenue in 2024
3.5 Global Key Players of Needle-Free Peptide Delivery Head office and Area Served
3.6 Global Key Players of Needle-Free Peptide Delivery, Product and Application
3.7 Global Key Players of Needle-Free Peptide Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Needle-Free Peptide Delivery Breakdown Data by Type
4.1 Global Needle-Free Peptide Delivery Historic Market Size by Type (2020-2025)
4.2 Global Needle-Free Peptide Delivery Forecasted Market Size by Type (2026-2031)
5 Needle-Free Peptide Delivery Breakdown Data by Application
5.1 Global Needle-Free Peptide Delivery Historic Market Size by Application (2020-2025)
5.2 Global Needle-Free Peptide Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Needle-Free Peptide Delivery Market Size (2020-2031)
6.2 North America Needle-Free Peptide Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Needle-Free Peptide Delivery Market Size by Country (2020-2025)
6.4 North America Needle-Free Peptide Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Needle-Free Peptide Delivery Market Size (2020-2031)
7.2 Europe Needle-Free Peptide Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Needle-Free Peptide Delivery Market Size by Country (2020-2025)
7.4 Europe Needle-Free Peptide Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Needle-Free Peptide Delivery Market Size (2020-2031)
8.2 Asia-Pacific Needle-Free Peptide Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Needle-Free Peptide Delivery Market Size (2020-2031)
9.2 Latin America Needle-Free Peptide Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Needle-Free Peptide Delivery Market Size by Country (2020-2025)
9.4 Latin America Needle-Free Peptide Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Needle-Free Peptide Delivery Market Size (2020-2031)
10.2 Middle East & Africa Needle-Free Peptide Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Details
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals Needle-Free Peptide Delivery Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 Portal Instruments
11.2.1 Portal Instruments Company Details
11.2.2 Portal Instruments Business Overview
11.2.3 Portal Instruments Needle-Free Peptide Delivery Introduction
11.2.4 Portal Instruments Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.2.5 Portal Instruments Recent Development
11.3 Crossject Société Anonyme
11.3.1 Crossject Société Anonyme Company Details
11.3.2 Crossject Société Anonyme Business Overview
11.3.3 Crossject Société Anonyme Needle-Free Peptide Delivery Introduction
11.3.4 Crossject Société Anonyme Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.3.5 Crossject Société Anonyme Recent Development
11.4 3M
11.4.1 3M Company Details
11.4.2 3M Business Overview
11.4.3 3M Needle-Free Peptide Delivery Introduction
11.4.4 3M Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.4.5 3M Recent Development
11.5 Antares Pharma
11.5.1 Antares Pharma Company Details
11.5.2 Antares Pharma Business Overview
11.5.3 Antares Pharma Needle-Free Peptide Delivery Introduction
11.5.4 Antares Pharma Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.5.5 Antares Pharma Recent Development
11.6 Zogenix
11.6.1 Zogenix Company Details
11.6.2 Zogenix Business Overview
11.6.3 Zogenix Needle-Free Peptide Delivery Introduction
11.6.4 Zogenix Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.6.5 Zogenix Recent Development
11.7 PharmaJet
11.7.1 PharmaJet Company Details
11.7.2 PharmaJet Business Overview
11.7.3 PharmaJet Needle-Free Peptide Delivery Introduction
11.7.4 PharmaJet Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.7.5 PharmaJet Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Details
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Needle-Free Peptide Delivery Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Details
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Needle-Free Peptide Delivery Introduction
11.9.4 Bioject Medical Technologies Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.9.5 Bioject Medical Technologies Recent Development
11.10 Valeritas
11.10.1 Valeritas Company Details
11.10.2 Valeritas Business Overview
11.10.3 Valeritas Needle-Free Peptide Delivery Introduction
11.10.4 Valeritas Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.10.5 Valeritas Recent Development
11.11 Takeda Pharmaceutical Company
11.11.1 Takeda Pharmaceutical Company Company Details
11.11.2 Takeda Pharmaceutical Company Business Overview
11.11.3 Takeda Pharmaceutical Company Needle-Free Peptide Delivery Introduction
11.11.4 Takeda Pharmaceutical Company Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.11.5 Takeda Pharmaceutical Company Recent Development
11.12 Medical International Technology
11.12.1 Medical International Technology Company Details
11.12.2 Medical International Technology Business Overview
11.12.3 Medical International Technology Needle-Free Peptide Delivery Introduction
11.12.4 Medical International Technology Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.12.5 Medical International Technology Recent Development
11.13 Endo International
11.13.1 Endo International Company Details
11.13.2 Endo International Business Overview
11.13.3 Endo International Needle-Free Peptide Delivery Introduction
11.13.4 Endo International Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.13.5 Endo International Recent Development
11.14 Akra Dermojet
11.14.1 Akra Dermojet Company Details
11.14.2 Akra Dermojet Business Overview
11.14.3 Akra Dermojet Needle-Free Peptide Delivery Introduction
11.14.4 Akra Dermojet Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.14.5 Akra Dermojet Recent Development
11.15 TheraJect
11.15.1 TheraJect Company Details
11.15.2 TheraJect Business Overview
11.15.3 TheraJect Needle-Free Peptide Delivery Introduction
11.15.4 TheraJect Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.15.5 TheraJect Recent Development
11.16 TARI Labs
11.16.1 TARI Labs Company Details
11.16.2 TARI Labs Business Overview
11.16.3 TARI Labs Needle-Free Peptide Delivery Introduction
11.16.4 TARI Labs Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.16.5 TARI Labs Recent Development
11.17 InsuJet
11.17.1 InsuJet Company Details
11.17.2 InsuJet Business Overview
11.17.3 InsuJet Needle-Free Peptide Delivery Introduction
11.17.4 InsuJet Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.17.5 InsuJet Recent Development
11.18 Gerresheimer AG
11.18.1 Gerresheimer AG Company Details
11.18.2 Gerresheimer AG Business Overview
11.18.3 Gerresheimer AG Needle-Free Peptide Delivery Introduction
11.18.4 Gerresheimer AG Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.18.5 Gerresheimer AG Recent Development
11.19 Mitsubishi Tanabe Pharma Corporation
11.19.1 Mitsubishi Tanabe Pharma Corporation Company Details
11.19.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.19.3 Mitsubishi Tanabe Pharma Corporation Needle-Free Peptide Delivery Introduction
11.19.4 Mitsubishi Tanabe Pharma Corporation Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.19.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.20 Novartis AG
11.20.1 Novartis AG Company Details
11.20.2 Novartis AG Business Overview
11.20.3 Novartis AG Needle-Free Peptide Delivery Introduction
11.20.4 Novartis AG Revenue in Needle-Free Peptide Delivery Business (2020-2025)
11.20.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Needle-Free Peptide Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Jet Injectors
Table 3. Key Players of Inhaler Technology
Table 4. Key Players of Transdermal Patch Technology
Table 5. Key Players of Electroporation
Table 6. Key Players of Laser-Powered Systems
Table 7. Key Players of Microporation
Table 8. Global Needle-Free Peptide Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Needle-Free Peptide Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Needle-Free Peptide Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Needle-Free Peptide Delivery Market Share by Region (2020-2025)
Table 12. Global Needle-Free Peptide Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Needle-Free Peptide Delivery Market Share by Region (2026-2031)
Table 14. Needle-Free Peptide Delivery Market Trends
Table 15. Needle-Free Peptide Delivery Market Drivers
Table 16. Needle-Free Peptide Delivery Market Challenges
Table 17. Needle-Free Peptide Delivery Market Restraints
Table 18. Global Needle-Free Peptide Delivery Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Needle-Free Peptide Delivery Market Share by Players (2020-2025)
Table 20. Global Top Needle-Free Peptide Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Peptide Delivery as of 2024)
Table 21. Ranking of Global Top Needle-Free Peptide Delivery Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Needle-Free Peptide Delivery Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Needle-Free Peptide Delivery, Headquarters and Area Served
Table 24. Global Key Players of Needle-Free Peptide Delivery, Product and Application
Table 25. Global Key Players of Needle-Free Peptide Delivery, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Needle-Free Peptide Delivery Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Needle-Free Peptide Delivery Revenue Market Share by Type (2020-2025)
Table 29. Global Needle-Free Peptide Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Needle-Free Peptide Delivery Revenue Market Share by Type (2026-2031)
Table 31. Global Needle-Free Peptide Delivery Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Needle-Free Peptide Delivery Revenue Market Share by Application (2020-2025)
Table 33. Global Needle-Free Peptide Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Needle-Free Peptide Delivery Revenue Market Share by Application (2026-2031)
Table 35. North America Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Needle-Free Peptide Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Needle-Free Peptide Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Needle-Free Peptide Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Needle-Free Peptide Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Needle-Free Peptide Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Needle-Free Peptide Delivery Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Needle-Free Peptide Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Needle-Free Peptide Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Needle-Free Peptide Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Needle-Free Peptide Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 50. Zynerba Pharmaceuticals Company Details
Table 51. Zynerba Pharmaceuticals Business Overview
Table 52. Zynerba Pharmaceuticals Needle-Free Peptide Delivery Product
Table 53. Zynerba Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 54. Zynerba Pharmaceuticals Recent Development
Table 55. Portal Instruments Company Details
Table 56. Portal Instruments Business Overview
Table 57. Portal Instruments Needle-Free Peptide Delivery Product
Table 58. Portal Instruments Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 59. Portal Instruments Recent Development
Table 60. Crossject Société Anonyme Company Details
Table 61. Crossject Société Anonyme Business Overview
Table 62. Crossject Société Anonyme Needle-Free Peptide Delivery Product
Table 63. Crossject Société Anonyme Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 64. Crossject Société Anonyme Recent Development
Table 65. 3M Company Details
Table 66. 3M Business Overview
Table 67. 3M Needle-Free Peptide Delivery Product
Table 68. 3M Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 69. 3M Recent Development
Table 70. Antares Pharma Company Details
Table 71. Antares Pharma Business Overview
Table 72. Antares Pharma Needle-Free Peptide Delivery Product
Table 73. Antares Pharma Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 74. Antares Pharma Recent Development
Table 75. Zogenix Company Details
Table 76. Zogenix Business Overview
Table 77. Zogenix Needle-Free Peptide Delivery Product
Table 78. Zogenix Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 79. Zogenix Recent Development
Table 80. PharmaJet Company Details
Table 81. PharmaJet Business Overview
Table 82. PharmaJet Needle-Free Peptide Delivery Product
Table 83. PharmaJet Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 84. PharmaJet Recent Development
Table 85. Inovio Pharmaceuticals Company Details
Table 86. Inovio Pharmaceuticals Business Overview
Table 87. Inovio Pharmaceuticals Needle-Free Peptide Delivery Product
Table 88. Inovio Pharmaceuticals Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 89. Inovio Pharmaceuticals Recent Development
Table 90. Bioject Medical Technologies Company Details
Table 91. Bioject Medical Technologies Business Overview
Table 92. Bioject Medical Technologies Needle-Free Peptide Delivery Product
Table 93. Bioject Medical Technologies Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 94. Bioject Medical Technologies Recent Development
Table 95. Valeritas Company Details
Table 96. Valeritas Business Overview
Table 97. Valeritas Needle-Free Peptide Delivery Product
Table 98. Valeritas Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 99. Valeritas Recent Development
Table 100. Takeda Pharmaceutical Company Company Details
Table 101. Takeda Pharmaceutical Company Business Overview
Table 102. Takeda Pharmaceutical Company Needle-Free Peptide Delivery Product
Table 103. Takeda Pharmaceutical Company Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 104. Takeda Pharmaceutical Company Recent Development
Table 105. Medical International Technology Company Details
Table 106. Medical International Technology Business Overview
Table 107. Medical International Technology Needle-Free Peptide Delivery Product
Table 108. Medical International Technology Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 109. Medical International Technology Recent Development
Table 110. Endo International Company Details
Table 111. Endo International Business Overview
Table 112. Endo International Needle-Free Peptide Delivery Product
Table 113. Endo International Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 114. Endo International Recent Development
Table 115. Akra Dermojet Company Details
Table 116. Akra Dermojet Business Overview
Table 117. Akra Dermojet Needle-Free Peptide Delivery Product
Table 118. Akra Dermojet Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 119. Akra Dermojet Recent Development
Table 120. TheraJect Company Details
Table 121. TheraJect Business Overview
Table 122. TheraJect Needle-Free Peptide Delivery Product
Table 123. TheraJect Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 124. TheraJect Recent Development
Table 125. TARI Labs Company Details
Table 126. TARI Labs Business Overview
Table 127. TARI Labs Needle-Free Peptide Delivery Product
Table 128. TARI Labs Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 129. TARI Labs Recent Development
Table 130. InsuJet Company Details
Table 131. InsuJet Business Overview
Table 132. InsuJet Needle-Free Peptide Delivery Product
Table 133. InsuJet Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 134. InsuJet Recent Development
Table 135. Gerresheimer AG Company Details
Table 136. Gerresheimer AG Business Overview
Table 137. Gerresheimer AG Needle-Free Peptide Delivery Product
Table 138. Gerresheimer AG Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 139. Gerresheimer AG Recent Development
Table 140. Mitsubishi Tanabe Pharma Corporation Company Details
Table 141. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 142. Mitsubishi Tanabe Pharma Corporation Needle-Free Peptide Delivery Product
Table 143. Mitsubishi Tanabe Pharma Corporation Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 144. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 145. Novartis AG Company Details
Table 146. Novartis AG Business Overview
Table 147. Novartis AG Needle-Free Peptide Delivery Product
Table 148. Novartis AG Revenue in Needle-Free Peptide Delivery Business (2020-2025) & (US$ Million)
Table 149. Novartis AG Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Needle-Free Peptide Delivery Picture
Figure 2. Global Needle-Free Peptide Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Needle-Free Peptide Delivery Market Share by Type: 2024 VS 2031
Figure 4. Jet Injectors Features
Figure 5. Inhaler Technology Features
Figure 6. Transdermal Patch Technology Features
Figure 7. Electroporation Features
Figure 8. Laser-Powered Systems Features
Figure 9. Microporation Features
Figure 10. Global Needle-Free Peptide Delivery Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Needle-Free Peptide Delivery Market Share by Application: 2024 VS 2031
Figure 12. Hospitals & Clinics Case Studies
Figure 13. Home Care Case Studies
Figure 14. Research Laboratories Case Studies
Figure 15. Pharmaceutical & Biotech Companies Case Studies
Figure 16. Others Case Studies
Figure 17. Needle-Free Peptide Delivery Report Years Considered
Figure 18. Global Needle-Free Peptide Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Needle-Free Peptide Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Needle-Free Peptide Delivery Market Share by Region: 2024 VS 2031
Figure 21. Global Needle-Free Peptide Delivery Market Share by Players in 2024
Figure 22. Global Needle-Free Peptide Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Needle-Free Peptide Delivery Revenue in 2024
Figure 24. North America Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Needle-Free Peptide Delivery Market Share by Country (2020-2031)
Figure 26. United States Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Needle-Free Peptide Delivery Market Share by Country (2020-2031)
Figure 30. Germany Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Needle-Free Peptide Delivery Market Share by Region (2020-2031)
Figure 38. China Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Needle-Free Peptide Delivery Market Share by Country (2020-2031)
Figure 46. Mexico Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Needle-Free Peptide Delivery Market Share by Country (2020-2031)
Figure 50. Israel Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Needle-Free Peptide Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Zynerba Pharmaceuticals Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 54. Portal Instruments Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 55. Crossject Société Anonyme Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 56. 3M Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 57. Antares Pharma Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 58. Zogenix Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 59. PharmaJet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 60. Inovio Pharmaceuticals Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 61. Bioject Medical Technologies Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 62. Valeritas Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 63. Takeda Pharmaceutical Company Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 64. Medical International Technology Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 65. Endo International Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 66. Akra Dermojet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 67. TheraJect Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 68. TARI Labs Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 69. InsuJet Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 70. Gerresheimer AG Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 71. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 72. Novartis AG Revenue Growth Rate in Needle-Free Peptide Delivery Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Needle-Free Peptide Delivery market?
The top companies in the global Needle-Free Peptide Delivery market are Zynerba Pharmaceuticals、Portal Instruments、Crossject Société Anonyme.
What was the global market size of Needle-Free Peptide Delivery in 2031?
What is the annual compound growth rate of the global Needle-Free Peptide Delivery market size from 2025 to 2031?
What was the global market size of Needle-Free Peptide Delivery in 2025?
Which region is expected to have the highest market share?
Related Reports
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Needle-Free Peptide Delivery market is projected to grow from US$ 343 million in 2025 to US$ 599 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 153
USD 4900.00
(Single User License)
Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Needle-Free Peptide Delivery market size was US$ 343 million in 2025 and is forecast to reach a readjusted size of US$ 599 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 108
USD 4250.00
(Single User License)
Global Needle-Free Peptide Delivery Market Research Report 2026
The global Needle-Free Peptide Delivery market was valued at US$ 343 million in 2025 and is anticipated to reach US$ 599 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 134
USD 2900.00
(Single User License)
Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 343 million in 2025 and is projected to reach US$ 599 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 132
USD 3950.00
(Single User License)
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Needle-Free Peptide Delivery market is projected to grow from US$ 296 million in 2024 to US$ 557 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 154
USD 4900.00
(Single User License)
Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-07-31
Pages: 130
USD 3950.00
(Single User License)
Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Needle-Free Peptide Delivery market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-07-31
Pages: 101
USD 4250.00
(Single User License)
Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Needle-Free Peptide Delivery market is projected to grow from US$ 343 million in 2025 to US$ 599 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 153
USD 4900.00 (Single User License)Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Needle-Free Peptide Delivery market size was US$ 343 million in 2025 and is forecast to reach a readjusted size of US$ 599 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 108
USD 4250.00 (Single User License)Global Needle-Free Peptide Delivery Market Research Report 2026
The global Needle-Free Peptide Delivery market was valued at US$ 343 million in 2025 and is anticipated to reach US$ 599 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-03-12
Pages: 134
USD 2900.00 (Single User License)Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 343 million in 2025 and is projected to reach US$ 599 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 132
USD 3950.00 (Single User License)Global Needle-Free Peptide Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Needle-Free Peptide Delivery market is projected to grow from US$ 296 million in 2024 to US$ 557 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 154
USD 4900.00 (Single User License)Needle-Free Peptide Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Needle-Free Peptide Delivery was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-07-31
Pages: 130
USD 3950.00 (Single User License)Global Needle-Free Peptide Delivery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Needle-Free Peptide Delivery market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 557 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-07-31
Pages: 101
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now